Open Access

[Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1

  • Authors:
    • Juan Xu
    • Nan Jiang
    • Haijuan Shi
    • Shanshan Zhao
    • Shuzhong Yao
    • Huimin Shen
  • View Affiliations

  • Published online on: April 27, 2017     https://doi.org/10.3892/ijo.2017.3977
  • Pages: 2236-2236
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Int J Oncol 50:[Related article:] 1383–1391, 2017

Following the publication of this article, the authors noted that there was an error in the affiliations. Specifically, the affiliation of the first author JUAN XU should be: Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang 321000, P.R. China.

Related Articles

Journal Cover

June-2017
Volume 50 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Jiang N, Shi H, Zhao S, Yao S and Shen H: [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1. Int J Oncol 50: 2236-2236, 2017
APA
Xu, J., Jiang, N., Shi, H., Zhao, S., Yao, S., & Shen, H. (2017). [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1. International Journal of Oncology, 50, 2236-2236. https://doi.org/10.3892/ijo.2017.3977
MLA
Xu, J., Jiang, N., Shi, H., Zhao, S., Yao, S., Shen, H."[Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1". International Journal of Oncology 50.6 (2017): 2236-2236.
Chicago
Xu, J., Jiang, N., Shi, H., Zhao, S., Yao, S., Shen, H."[Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1". International Journal of Oncology 50, no. 6 (2017): 2236-2236. https://doi.org/10.3892/ijo.2017.3977